Business Intelligence Software
Reveleer is a healthcare technology company operating at the intersection of value-based care, artificial intelligence, and workflow automation. The company connects payers (insurance companies) and providers (health systems and physicians) to improve patient outcomes by ingesting, distilling, and acting on massive volumes of clinical data. CEO Jay Ackerman has led the company for eight years, guiding it from roughly $1 million in early revenue to a projected $100 million in 2024. Reveleer's growth has accelerated sharply in recent years, moving from $25 million to $50 million in 2023 and targeting $100 million in 2024, a 100 percent year-over-year increase. The company has pursued a disciplined acquisition strategy, closing two deals since early 2022 to expand its product suite and total addressable market, which now stands at approximately $20 billion. A $65 million venture debt raise in 2024 with Hercules Capital is funding a planned third acquisition. The company counts roughly 70 enterprise logos as customers, with average contract values rising from under $200,000 in 2021 to over $800,000 in 2024. Reveleer ingests approximately 1 billion pages of medical records annually at a rate of 3,000 pages per minute, a data processing capability Ackerman describes as the company's core competitive advantage. Institutional equity backers include OakHCFT and Upfront Ventures.
- Revenue
- $100M
- Customers
- 70
- Year founded
- 2013
- Funding
- $190.8M
- Team size
- 292
- Location
- United States